Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin
TL;DR
Erin Davis calls it the “SuperDuperPOD. ” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it. And they’re doubling down. BMS announced today it is deploying its second NVIDIA DGX SuperPOD, this one built on […].
Nauti's Take
Small teams should not read this as a cue to chase giant compute clusters. The practical check is which parts of your workflow truly improve with more GPU capacity and where data quality, validation, and domain expertise are still the real bottlenecks.
The source base is thin here because the announcement comes from NVIDIA, and concrete details on cost, utilization, and research impact are still missing.
Summary
Erin Davis calls it the “SuperDuperPOD. ” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it.
And they’re doubling down. BMS announced today it is deploying its second NVIDIA DGX SuperPOD, this one built on […]
Sources